BioAge Labs (BIOA) Net Cash Flow (2023 - 2026)

BioAge Labs has disclosed Net Cash Flow across 4 years of filings, most recently posting $52.9 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $52.9 million, up 154.64% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.6 million (down 119.48% YoY), and the FY2025 annual result was -$165.4 million, down 150.22% from the prior year.
• Net Cash Flow came in at $52.9 million for Q1 2026 at BioAge Labs, up from -$26.7 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $175.4 million in Q3 2024 to a low of -$96.9 million in Q1 2025.
• The 4-year median for Net Cash Flow is -$7.1 million (2023), against an average of $20.7 million.
• Across the five-year window, Net Cash Flow soared 307.51% in 2024 and tumbled 235.1% in 2025, its largest moves.
• BioAge Labs' Net Cash Flow stood at -$9.5 million in 2023, then soared by 307.51% to $19.7 million in 2024, then sank by 235.1% to -$26.7 million in 2025, then surged by 298.44% to $52.9 million in 2026.
• The last three Net Cash Flow figures came in at $52.9 million (Q1 2026), -$26.7 million (Q4 2025), and -$4.7 million (Q3 2025), per Business Quant data.